Astal Laboratories Intrinsic Value
Astal Laboratories (ASTALLTD) median intrinsic value is ₹57.14 from 8 valuation models (range ₹24–₹102), vs current price ₹80.70 — -29.2% downside (Trading Above Calculated Value), margin of safety -41.2%. For current market price and key ratios, visit Astal Laboratories share price today.
ASTALLTD Valuation Methods Summary — DCF, Graham Number & P/E
Astal Laboratories intrinsic value across 8 models vs current price ₹80.70 — upside/downside and value range per method. Also explore ASTALLTD stock price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹24.21 | ₹19.37 - ₹29.05 | -70.0% | EPS: ₹1.16, Sector P/E: 12x |
| Book Value Method | asset | ₹77.86 | ₹70.07 - ₹85.65 | -3.5% | Book Value/Share: ₹77.86, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹102.10 | ₹91.89 - ₹112.31 | +26.5% | Revenue/Share: ₹127.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹57.14 | ₹51.43 - ₹62.85 | -29.2% | EBITDA: ₹40.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹24.21 | ₹21.79 - ₹26.63 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹24.21 | ₹21.79 - ₹26.63 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹76.19 | ₹68.57 - ₹83.81 | -5.6% | ROE: 9.8%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹45.08 | ₹40.57 - ₹49.59 | -44.1% | EPS: ₹1.16, BVPS: ₹77.86 |
ASTALLTD Intrinsic Value vs Market Price — All Valuation Models
Astal Laboratories fair value range ₹24–₹102 vs current market price ₹80.70 across 8 valuation models. Browse ASTALLTD complete financial statements for revenue, profit, balance sheet and cash flow data.
ASTALLTD Intrinsic Value Analysis — Undervalued or Overvalued?
Astal Laboratories median intrinsic value ₹57.14, current price ₹80.70 — Trading Above Calculated Value by 29.2%, margin of safety -41.2%.
What is the intrinsic value of ASTALLTD?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Astal Laboratories (ASTALLTD) is ₹57.14 (median value). With the current market price of ₹80.70, this represents a -29.2% variance from our estimated fair value.
The valuation range spans from ₹24.21 to ₹102.10, indicating ₹24.21 - ₹102.10.
Is ASTALLTD undervalued or overvalued?
Based on our multi-method analysis, Astal Laboratories (ASTALLTD) appears to be trading above calculated value by approximately 29.2%.
ASTALLTD Financial Health — Key Ratios vs Industry Benchmarks
Astal Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 103.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.34x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ASTALLTD Cash Flow Quality — Operating & Free Cash Flow
Astal Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-13 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |